New from McKinsey & Company

When will the COVID-19 pandemic end?

Europe and the United States have entered the endemic stage of the COVID-19 outbreak: the virus is widespread, is significantly less fatal than it was in 2020, and is spurring only limited changes in public behavior. These endemic conditions are likely to continue through the summer and autumn, unless and until immunity-evading new variants emerge. As immunity wanes, however, the next stage remains highly uncertain. In this update, we discuss the outlook, the current and potential future use of boosters and therapeutics, and the shifts in response strategies to the COVID-19 crisis around the world. We also introduce the McKinsey COVID-19 Immunity Index—a tool for understanding a community's current level of risk from the disease.

Prepare yourself

Related Reading

Image of a woman wearing a medical face mask

COVID-19: Where we've been, where we are, and where we're going

How COVID-19 caused a global learning crisis

Follow our thinking

McKinsey Insights - Get our latest thinking on your iPhone, iPad or Android.

Share these insights

Did you enjoy this email? Forward it to colleagues and friends so they can subscribe too. Was this alert forwarded to you? Sign up for it and sample our 40+ other free email subscriptions here.

This email contains information about McKinsey's research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy.

You received this email because you subscribed to our Healthcare Systems & Services alert list.

Manage subscriptions | Unsubscribe

Newsletters

When will the COVID-19 pandemic end?

When will the COVID-19 pandemic end?

No comments: